Literature DB >> 6281718

Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum.

P D Griffiths, S Stagno, R F Pass, R J Smith, C A Alford.   

Abstract

Specific immunoglobulin M antibodies were detected by radioimmunoassay (RIA-IgM) in cord sera from 83/93 (89%) babies congenitally infected with cytomegalovirus (CMV) but in 0/104 cord sera from uninfected control subjects. The type of maternal infection did not affect the ability of the assay to identify congenital infections, but increased RIA-IgM titers were found more frequently in cord sera from babies infected following primary CMV infections (9/18; 50%) than following recurrent CMV infections (1/12; 8%) (P less than .05). The magnitude of the fetal immune response was related to disease inasmuch as 14/40 (35%) babies with increased RIA-IgM titers were symptomatic at birth compared with 1/43 (2%) with lower titers (P less than .001). When combined with the results of testing for rheumatoid factor and total IgM, the RIA-IgM assay defined subgroups of babies with generally poor (7/15; 47% symptomatic at any stage) or generally good (0/21 symptomatic) prognoses. Prospective studies currently identifying cases of congenital CMV infection may wish to use these three serologic techniques as the results obtained appear to have prognostic significance for those babies who are initially asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281718

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

1.  Confirmation of human cytomegalovirus by reverse passive hemagglutination with monoclonal antibodies reactive to the major glycosylated peptide (GP-66).

Authors:  K S Kim; V Sapienza; C M Chen
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

2.  Congenital cytomegalovirus infection.

Authors:  J M Best
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

Review 3.  The status of CMV as a human pathogen.

Authors:  P D Griffiths; J E Grundy
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

4.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

5.  Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Specific and non-specific serological markers in the screening for congenital CMV infection.

Authors:  A el-Mekki; L V Deverajan; S Soufi; O Strannegard; W al-Nakib
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

7.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

Authors:  J M Middeldorp; J Jongsma; A ter Haar; J Schirm; T H The
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

8.  Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; C M Chen; K Wisniewski
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

9.  Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci.

Authors:  B F Anthony; N F Concepcion; C A Wass; D C Heiner
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

10.  Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections.

Authors:  L Pereira; S Stagno; M Hoffman; J E Volanakis
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.